The Waszak Group
The Computational Oncology Group at the Centre for Molecular Medicine Norway (NCMM) focuses on precision medicine for young people with cancer. The group is led by Dr. Sebastian Waszak.
We combine approaches from population genomics, cancer genomics, and cancer systems genetics to understand the genetic basis of cancer, somatic evolution of cancer cells, and the mechanisms that drive genome and proteome instability in cancer. Our long-term aim is to improve diagnosis, prognosis, and therapeutic recommendations for young patients with cancer, in particular children with aggressive brain tumors.